TRANSGENE SA (TNG.PA) Stock Income Statement
Europe - EPA:TNG - FR0005175080 - Common Stock
1.32 EUR
+0.02 (+1.54%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 6.08M | 7.63M | 10.00M | 17.01M | 9.34M | |||
| Operating Expenses | 41.74M | 37.65M | 39.90M | 40.53M | 33.34M | |||
| Research and Development | 26.20M | 22.07M | 25.13M | 25.97M | 21.00M | |||
| Selling, General, and Administrative Expenses | 7.73M | 6.93M | 7.85M | 7.31M | 6.49M | |||
| Operating Income | -35.66M | -30.01M | -29.90M | -23.52M | -23.99M | |||
| Interest Income/Expense | 462.00K | 213.00K | -381.00K | -209.00K | -1.25M | |||
| Other Income/Expense | 1.23M | 7.51M | -2.52M | 4.20M | 8.02M | |||
| Non Recurring Items | -3.00K | -35.00K | -6.00K | -4.00K | 0.00 | |||
| Income Before Taxes | -33.97M | -22.33M | -32.80M | -19.54M | -17.23M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -33.97M | -22.33M | -32.80M | -19.54M | -17.23M | |||
| EBITDA | -34.37M | -28.44M | -28.21M | -21.00M | -22.21M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.29 | -0.22 | -0.33 | -0.21 | -0.21 | |||
| Statistics | ||||||||
| Profit Margin | -558.64% | -292.48% | -327.97% | -114.82% | -184.43% | |||
| Operating Profit Margin | -586.33% | -393.14% | -298.92% | -138.24% | -256.80% | |||
All data in EUR